The main objective of this project is to test whether EMDR therapy is effective in reducing substance use and improving clinical and trauma-related symptoms in SUD patients with a history of psychological trauma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Reduction in severity of consumption
Timeframe: Changes from baseline to visits at 3, 6 and 12 months.
Reduction in level of consumption
Timeframe: Changes from baseline to visits at 3, 6 and 12 months.
Reduction in the number of relapses
Timeframe: Change of relapses from baseline to visits at 3, 6 and 12 months.
Reduction of (hypo) manic symptoms associated with a comorbid psychiatric disorder
Timeframe: Changes from baseline to visits at 6 and 12 months.
Reduction of general psychopathological symptoms associated with psychiatric comorbidity
Timeframe: Change from baseline to visits at 6 and 12 months.
Reduction in depressive symptoms associated with a comorbid psychiatric disorder
Timeframe: Changes from baseline to visits at 6 and 12 months.